Latest Coronavirus Disease COVID 19 News and Research
University of Utah Health, Intermountain Healthcare launch two clinical trials to treat COVID-19 patients
Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).
Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment
Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital.
Quantifying the risk among health care providers who intubate COVID-19 patients
A team at the Perelman School of Medicine at the University of Pennsylvania launched the United States component of a global registry that aims to help protect health care providers who intubate patients with COVID-19 and better quantify their risk of developing the disease.
Phylogenetic network analysis provides ‘snapshot’ of COVID-19 origins
Researchers from Cambridge, UK, and Germany have reconstructed the early "evolutionary paths" of COVID-19 in humans - as infection spread from Wuhan out to Europe and North America - using genetic network techniques.
Newsom’s ambitious health care agenda crumbles in a ‘radically changed’ world
This was supposed to be a big health care year for California.
What’s missing in the coronavirus response
In the age of coronavirus, Americans are being told to stay home and wear masks outside. The federal government has made way for hospitals to treat patients in repurposed hotels and dormitories. Private companies are working to push out new diagnostic tests.
What does recovery from COVID-19 look like? It depends. A pulmonologist explains.
Reports of recovery from serious illness caused by the coronavirus have been trickling in from around the world.
COVID-19 crisis threatens beleaguered assisted living industry
David Aguirre jumped in his truck and drove toward the hospital in the predawn darkness the minute he got the news: His 91-year-old mom was being rushed from her Texas assisted living facility to the emergency room.
Novel coronavirus targets specific secretory cells in the lungs
Viruses attack specific host cells, which can cause chaos in the body. The novel coronavirus, now called severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 for short, infects respiratory epithelial cells in the lining of the lung, causing difficulty of breathing. The usual cause of death of those who contract the virus is pneumonia and acute respiratory distress syndrome (ARDS). Now, a new study has found that SARS-CoV-2 specifically attack certain progenitor cells called bronchial transient secretory cells in the lungs.
Avacta partners with Cytiva to develop a rapid test for COVID-19
Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences.
_bced656e24224054894a75862d14fa09-150x125.jpg "Chinese newborns experienced mild form of COVID-19")
Chinese newborns experienced mild form of COVID-19
A new paper published by Dr. Zhi-Jiang Zhang and colleagues from Wuhan University in the European Respiratory Journal in April 2020 reports that COVID-19 apparently left little impact on newborns born to infected mothers at the height of the epidemic.
Georgetown University Venture Lab startups launch The COVID-19 Testing Locator
The Social App and Basil Labs—two startups in the Georgetown University Venture Lab, which is funded by the Lenosis family, have launched The COVID-19 Testing Locator to provide a free utility for anyone in the United States to locate nearby testing locations.
Smokers have more ACE2 receptors making it easier for SARS-CoV-2 to infect
A new study published in the European Respiratory Journal in April 2020 reveals that people with smoking-damaged lungs and those with chronic obstructive pulmonary disease (COPD) are likely to have a higher level of the angiotensin-converting enzyme II (ACE2).
Ai used to detect COVID-19 pneumonia
Coronaviruses have 'spilled over' to human populations throughout history, causing respiratory illnesses, often associated with pneumonia. The severe acute respiratory syndrome (SARS), which emerged in 2002 in China, and the Middle East Respiratory Syndrome (MERS), which was first seen in Saudi Arabia in 2012, are similar to the current global pandemic spreading worldwide, the coronavirus disease (COVID-19).
PIV5-based MERS vaccine shows promise for COVID-19
The coronavirus disease (COVID-19) has spread to 184 countries and territories. Currently, there is no vaccine available for COVID-19 disease, or SARS-CoV-2 infection. However, scientists around the world are racing to find ways to block the virus.
Top NAU microbiologist joins Arizona COVID-19 Genomics Union
The Translational Genomics Research Institute, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern Arizona University and the Ecology and Evolutionary Biology Department at the University of Arizona have formed a union dedicated to tracking the COVID-19 coronavirus, it was announced today.
More than half of COVID-19 patients in Brazil came from Italy
Italy has grappled with the coronavirus disease (COVID-19), with more than 139,000 people infected and more than 17,000 people dead. In the first week of March, the number of cases in Italy skyrocketed before the lockdown was set in place. Prior to the country shutting down its border, many people had already left, flocking to other countries in an attempt to escape the virus.
Philadelphia Eagles owner contributes $1 million to Penn Medicine to fight COVID-19 pandemic
Philadelphia Eagles owner Jeffrey Lurie today announced a $1 million contribution to Penn Medicine to establish the COVID-19 Immunology Defense Fund, laying the foundation for the world's foremost experts to fight the novel coronavirus pandemic.
Air pollution and PM2.5 raise risk of COVID-19 death
According to a new analysis, air pollution is associated with more deaths in the currently raging COVID-19 pandemic. A new American study from researchers at Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, showed that a single unit increase in particle pollution levels in the air could raise the risk of death by 15 percent and that before this pandemic if the air was cleaner, it could have saved many lives.
Ebola drug now being tested against COVID-19
As the coronavirus pandemic claims lives and overwhelms health care systems throughout the world, scientists are closely watching several late-stage trials of the antiviral drug remdesivir.
No hay comentarios:
Publicar un comentario